Global Artificial Eye
Global Artificial Eye

Artificial Eye Comprehensive Study by Type (Non-Integrated Implants, Integrated Implants), Application (Hospital, Exhibition, Others, Player) Players and Region - Global Market Outlook to 2026

Artificial Eye Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 245 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Artificial Eye Market Scope
Artificial Eye is a manufactured eye that is made of glass, plastic, or other material. Artificial Eye is usually hemispherical or cup-shaped, worn cosmetically over a blind eye or in the socket of a lost eye which is attached to muscles to provide movement for the eye. Geographically, North America dominates the artificial eye market due to a rise in product innovations, an increase in the presence of leading players, a rise in the favourable reimbursement policies and high adoption of artificial eye surgeries in this region. Artificial Eye market has several positive factors which is triggering the growth of the market over the forecast period

The Artificial Eye market study is segmented by Type (Non-Integrated Implants and Integrated Implants), by Application (Hospital, Exhibition, Others and Player) and major geographies with country level break-up.

The market is expected to grow market in the medical and cosmetics industry. It has wide application for visual prosthetic systems is driving the demand for the market. Several companies are operating in the market to provide customers with better offers with various features & unique offerings. The market is a partially fragmented market with the presence of several market players and local players. Which is triggering the market growth over the forecast period

Erickson Laboratories (Sweden), Integrated Orbital Implants (United States), Ocular Prosthetics (United States), SECOND SIGH (United States), BioSpace (United States), Factor2 (United States), WebMD LLC (United States), Medical Research Foundation (India), Northwest eye design (United States), AEDI (United States), Midwest Eye Laboratories (United States), National Artificial Eye Service (United States), Curzon Group (United Kingdom) and Others are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Artificial Eye market by Type, Application and Region.

On the basis of geography, the market of Artificial Eye has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 23 December 2019 Curzon group has acquired US indie distributor and exhibitor Cohen Media Group



Market Trend
  • Rising demand for the bionic eye than prosthetic eyes
  • Artificial intelligence (AI) is a trending technology for screening, diagnosing, and helping treat eye conditions

Market Drivers
  • Rapid development in technology such as laser surgery
  • Huge demand for the cosmetic appearance

Opportunities
  • Huge demand for Bionic Eye disruptive technologies which work on existing eye structures or in the brain

Restraints
  • High cost of treatment

Challenges
  • It is not feasible for low power retina patient


Key Target Audience
Individual, Supplier, Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Artificial Eye Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Type
  • Non-Integrated Implants
  • Integrated Implants
By Application
  • Hospital
  • Exhibition
  • Others
  • Player
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rapid development in technology such as laser surgery
      • 3.2.2. Huge demand for the cosmetic appearance
    • 3.3. Market Challenges
      • 3.3.1. It is not feasible for low power retina patient
    • 3.4. Market Trends
      • 3.4.1. Rising demand for the bionic eye than prosthetic eyes
      • 3.4.2. Artificial intelligence (AI) is a trending technology for screening, diagnosing, and helping treat eye conditions
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Eye, by Type, Application and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Artificial Eye (Value)
      • 5.2.1. Global Artificial Eye by: Type (Value)
        • 5.2.1.1. Non-Integrated Implants
        • 5.2.1.2. Integrated Implants
      • 5.2.2. Global Artificial Eye by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Exhibition
        • 5.2.2.3. Others
        • 5.2.2.4. Player
      • 5.2.3. Global Artificial Eye Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Artificial Eye (Price)
      • 5.3.1. Global Artificial Eye by: Type (Price)
  • 6. Artificial Eye: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Erickson Laboratories (Sweden)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Integrated Orbital Implants (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ocular Prosthetics (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. SECOND SIGH (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioSpace (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Factor2 (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. WebMD LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medical Research Foundation (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Northwest eye design (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AEDI (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Midwest Eye Laboratories (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. National Artificial Eye Service (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Curzon Group (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Others
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Artificial Eye Sale, by Type, Application and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Artificial Eye (Value)
      • 7.2.1. Global Artificial Eye by: Type (Value)
        • 7.2.1.1. Non-Integrated Implants
        • 7.2.1.2. Integrated Implants
      • 7.2.2. Global Artificial Eye by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Exhibition
        • 7.2.2.3. Others
        • 7.2.2.4. Player
      • 7.2.3. Global Artificial Eye Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Artificial Eye (Price)
      • 7.3.1. Global Artificial Eye by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Eye: by Type(USD Million)
  • Table 2. Artificial Eye Non-Integrated Implants , by Region USD Million (2015-2020)
  • Table 3. Artificial Eye Integrated Implants , by Region USD Million (2015-2020)
  • Table 4. Artificial Eye: by Application(USD Million)
  • Table 5. Artificial Eye Hospital , by Region USD Million (2015-2020)
  • Table 6. Artificial Eye Exhibition , by Region USD Million (2015-2020)
  • Table 7. Artificial Eye Others , by Region USD Million (2015-2020)
  • Table 8. Artificial Eye Player , by Region USD Million (2015-2020)
  • Table 9. South America Artificial Eye, by Country USD Million (2015-2020)
  • Table 10. South America Artificial Eye, by Type USD Million (2015-2020)
  • Table 11. South America Artificial Eye, by Application USD Million (2015-2020)
  • Table 12. Brazil Artificial Eye, by Type USD Million (2015-2020)
  • Table 13. Brazil Artificial Eye, by Application USD Million (2015-2020)
  • Table 14. Argentina Artificial Eye, by Type USD Million (2015-2020)
  • Table 15. Argentina Artificial Eye, by Application USD Million (2015-2020)
  • Table 16. Rest of South America Artificial Eye, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Artificial Eye, by Application USD Million (2015-2020)
  • Table 18. Asia Pacific Artificial Eye, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Artificial Eye, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Artificial Eye, by Application USD Million (2015-2020)
  • Table 21. China Artificial Eye, by Type USD Million (2015-2020)
  • Table 22. China Artificial Eye, by Application USD Million (2015-2020)
  • Table 23. Japan Artificial Eye, by Type USD Million (2015-2020)
  • Table 24. Japan Artificial Eye, by Application USD Million (2015-2020)
  • Table 25. India Artificial Eye, by Type USD Million (2015-2020)
  • Table 26. India Artificial Eye, by Application USD Million (2015-2020)
  • Table 27. South Korea Artificial Eye, by Type USD Million (2015-2020)
  • Table 28. South Korea Artificial Eye, by Application USD Million (2015-2020)
  • Table 29. Taiwan Artificial Eye, by Type USD Million (2015-2020)
  • Table 30. Taiwan Artificial Eye, by Application USD Million (2015-2020)
  • Table 31. Australia Artificial Eye, by Type USD Million (2015-2020)
  • Table 32. Australia Artificial Eye, by Application USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Artificial Eye, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Artificial Eye, by Application USD Million (2015-2020)
  • Table 35. Europe Artificial Eye, by Country USD Million (2015-2020)
  • Table 36. Europe Artificial Eye, by Type USD Million (2015-2020)
  • Table 37. Europe Artificial Eye, by Application USD Million (2015-2020)
  • Table 38. Germany Artificial Eye, by Type USD Million (2015-2020)
  • Table 39. Germany Artificial Eye, by Application USD Million (2015-2020)
  • Table 40. France Artificial Eye, by Type USD Million (2015-2020)
  • Table 41. France Artificial Eye, by Application USD Million (2015-2020)
  • Table 42. Italy Artificial Eye, by Type USD Million (2015-2020)
  • Table 43. Italy Artificial Eye, by Application USD Million (2015-2020)
  • Table 44. United Kingdom Artificial Eye, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Artificial Eye, by Application USD Million (2015-2020)
  • Table 46. Netherlands Artificial Eye, by Type USD Million (2015-2020)
  • Table 47. Netherlands Artificial Eye, by Application USD Million (2015-2020)
  • Table 48. Rest of Europe Artificial Eye, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Artificial Eye, by Application USD Million (2015-2020)
  • Table 50. MEA Artificial Eye, by Country USD Million (2015-2020)
  • Table 51. MEA Artificial Eye, by Type USD Million (2015-2020)
  • Table 52. MEA Artificial Eye, by Application USD Million (2015-2020)
  • Table 53. Middle East Artificial Eye, by Type USD Million (2015-2020)
  • Table 54. Middle East Artificial Eye, by Application USD Million (2015-2020)
  • Table 55. Africa Artificial Eye, by Type USD Million (2015-2020)
  • Table 56. Africa Artificial Eye, by Application USD Million (2015-2020)
  • Table 57. North America Artificial Eye, by Country USD Million (2015-2020)
  • Table 58. North America Artificial Eye, by Type USD Million (2015-2020)
  • Table 59. North America Artificial Eye, by Application USD Million (2015-2020)
  • Table 60. United States Artificial Eye, by Type USD Million (2015-2020)
  • Table 61. United States Artificial Eye, by Application USD Million (2015-2020)
  • Table 62. Canada Artificial Eye, by Type USD Million (2015-2020)
  • Table 63. Canada Artificial Eye, by Application USD Million (2015-2020)
  • Table 64. Mexico Artificial Eye, by Type USD Million (2015-2020)
  • Table 65. Mexico Artificial Eye, by Application USD Million (2015-2020)
  • Table 66. Artificial Eye: by Type(USD/Units)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Artificial Eye: by Type(USD Million)
  • Table 82. Artificial Eye Non-Integrated Implants , by Region USD Million (2021-2026)
  • Table 83. Artificial Eye Integrated Implants , by Region USD Million (2021-2026)
  • Table 84. Artificial Eye: by Application(USD Million)
  • Table 85. Artificial Eye Hospital , by Region USD Million (2021-2026)
  • Table 86. Artificial Eye Exhibition , by Region USD Million (2021-2026)
  • Table 87. Artificial Eye Others , by Region USD Million (2021-2026)
  • Table 88. Artificial Eye Player , by Region USD Million (2021-2026)
  • Table 89. South America Artificial Eye, by Country USD Million (2021-2026)
  • Table 90. South America Artificial Eye, by Type USD Million (2021-2026)
  • Table 91. South America Artificial Eye, by Application USD Million (2021-2026)
  • Table 92. Brazil Artificial Eye, by Type USD Million (2021-2026)
  • Table 93. Brazil Artificial Eye, by Application USD Million (2021-2026)
  • Table 94. Argentina Artificial Eye, by Type USD Million (2021-2026)
  • Table 95. Argentina Artificial Eye, by Application USD Million (2021-2026)
  • Table 96. Rest of South America Artificial Eye, by Type USD Million (2021-2026)
  • Table 97. Rest of South America Artificial Eye, by Application USD Million (2021-2026)
  • Table 98. Asia Pacific Artificial Eye, by Country USD Million (2021-2026)
  • Table 99. Asia Pacific Artificial Eye, by Type USD Million (2021-2026)
  • Table 100. Asia Pacific Artificial Eye, by Application USD Million (2021-2026)
  • Table 101. China Artificial Eye, by Type USD Million (2021-2026)
  • Table 102. China Artificial Eye, by Application USD Million (2021-2026)
  • Table 103. Japan Artificial Eye, by Type USD Million (2021-2026)
  • Table 104. Japan Artificial Eye, by Application USD Million (2021-2026)
  • Table 105. India Artificial Eye, by Type USD Million (2021-2026)
  • Table 106. India Artificial Eye, by Application USD Million (2021-2026)
  • Table 107. South Korea Artificial Eye, by Type USD Million (2021-2026)
  • Table 108. South Korea Artificial Eye, by Application USD Million (2021-2026)
  • Table 109. Taiwan Artificial Eye, by Type USD Million (2021-2026)
  • Table 110. Taiwan Artificial Eye, by Application USD Million (2021-2026)
  • Table 111. Australia Artificial Eye, by Type USD Million (2021-2026)
  • Table 112. Australia Artificial Eye, by Application USD Million (2021-2026)
  • Table 113. Rest of Asia-Pacific Artificial Eye, by Type USD Million (2021-2026)
  • Table 114. Rest of Asia-Pacific Artificial Eye, by Application USD Million (2021-2026)
  • Table 115. Europe Artificial Eye, by Country USD Million (2021-2026)
  • Table 116. Europe Artificial Eye, by Type USD Million (2021-2026)
  • Table 117. Europe Artificial Eye, by Application USD Million (2021-2026)
  • Table 118. Germany Artificial Eye, by Type USD Million (2021-2026)
  • Table 119. Germany Artificial Eye, by Application USD Million (2021-2026)
  • Table 120. France Artificial Eye, by Type USD Million (2021-2026)
  • Table 121. France Artificial Eye, by Application USD Million (2021-2026)
  • Table 122. Italy Artificial Eye, by Type USD Million (2021-2026)
  • Table 123. Italy Artificial Eye, by Application USD Million (2021-2026)
  • Table 124. United Kingdom Artificial Eye, by Type USD Million (2021-2026)
  • Table 125. United Kingdom Artificial Eye, by Application USD Million (2021-2026)
  • Table 126. Netherlands Artificial Eye, by Type USD Million (2021-2026)
  • Table 127. Netherlands Artificial Eye, by Application USD Million (2021-2026)
  • Table 128. Rest of Europe Artificial Eye, by Type USD Million (2021-2026)
  • Table 129. Rest of Europe Artificial Eye, by Application USD Million (2021-2026)
  • Table 130. MEA Artificial Eye, by Country USD Million (2021-2026)
  • Table 131. MEA Artificial Eye, by Type USD Million (2021-2026)
  • Table 132. MEA Artificial Eye, by Application USD Million (2021-2026)
  • Table 133. Middle East Artificial Eye, by Type USD Million (2021-2026)
  • Table 134. Middle East Artificial Eye, by Application USD Million (2021-2026)
  • Table 135. Africa Artificial Eye, by Type USD Million (2021-2026)
  • Table 136. Africa Artificial Eye, by Application USD Million (2021-2026)
  • Table 137. North America Artificial Eye, by Country USD Million (2021-2026)
  • Table 138. North America Artificial Eye, by Type USD Million (2021-2026)
  • Table 139. North America Artificial Eye, by Application USD Million (2021-2026)
  • Table 140. United States Artificial Eye, by Type USD Million (2021-2026)
  • Table 141. United States Artificial Eye, by Application USD Million (2021-2026)
  • Table 142. Canada Artificial Eye, by Type USD Million (2021-2026)
  • Table 143. Canada Artificial Eye, by Application USD Million (2021-2026)
  • Table 144. Mexico Artificial Eye, by Type USD Million (2021-2026)
  • Table 145. Mexico Artificial Eye, by Application USD Million (2021-2026)
  • Table 146. Artificial Eye: by Type(USD/Units)
  • Table 147. Research Programs/Design for This Report
  • Table 148. Key Data Information from Secondary Sources
  • Table 149. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Eye: by Type USD Million (2015-2020)
  • Figure 5. Global Artificial Eye: by Application USD Million (2015-2020)
  • Figure 6. South America Artificial Eye Share (%), by Country
  • Figure 7. Asia Pacific Artificial Eye Share (%), by Country
  • Figure 8. Europe Artificial Eye Share (%), by Country
  • Figure 9. MEA Artificial Eye Share (%), by Country
  • Figure 10. North America Artificial Eye Share (%), by Country
  • Figure 11. Global Artificial Eye: by Type USD/Units (2015-2020)
  • Figure 12. Global Artificial Eye share by Players 2020 (%)
  • Figure 13. Global Artificial Eye share by Players (Top 3) 2020(%)
  • Figure 14. Global Artificial Eye share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Erickson Laboratories (Sweden) Revenue, Net Income and Gross profit
  • Figure 17. Erickson Laboratories (Sweden) Revenue: by Geography 2020
  • Figure 18. Integrated Orbital Implants (United States) Revenue, Net Income and Gross profit
  • Figure 19. Integrated Orbital Implants (United States) Revenue: by Geography 2020
  • Figure 20. Ocular Prosthetics (United States) Revenue, Net Income and Gross profit
  • Figure 21. Ocular Prosthetics (United States) Revenue: by Geography 2020
  • Figure 22. SECOND SIGH (United States) Revenue, Net Income and Gross profit
  • Figure 23. SECOND SIGH (United States) Revenue: by Geography 2020
  • Figure 24. BioSpace (United States) Revenue, Net Income and Gross profit
  • Figure 25. BioSpace (United States) Revenue: by Geography 2020
  • Figure 26. Factor2 (United States) Revenue, Net Income and Gross profit
  • Figure 27. Factor2 (United States) Revenue: by Geography 2020
  • Figure 28. WebMD LLC (United States) Revenue, Net Income and Gross profit
  • Figure 29. WebMD LLC (United States) Revenue: by Geography 2020
  • Figure 30. Medical Research Foundation (India) Revenue, Net Income and Gross profit
  • Figure 31. Medical Research Foundation (India) Revenue: by Geography 2020
  • Figure 32. Northwest eye design (United States) Revenue, Net Income and Gross profit
  • Figure 33. Northwest eye design (United States) Revenue: by Geography 2020
  • Figure 34. AEDI (United States) Revenue, Net Income and Gross profit
  • Figure 35. AEDI (United States) Revenue: by Geography 2020
  • Figure 36. Midwest Eye Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 37. Midwest Eye Laboratories (United States) Revenue: by Geography 2020
  • Figure 38. National Artificial Eye Service (United States) Revenue, Net Income and Gross profit
  • Figure 39. National Artificial Eye Service (United States) Revenue: by Geography 2020
  • Figure 40. Curzon Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 41. Curzon Group (United Kingdom) Revenue: by Geography 2020
  • Figure 42. Others Revenue, Net Income and Gross profit
  • Figure 43. Others Revenue: by Geography 2020
  • Figure 44. Global Artificial Eye: by Type USD Million (2021-2026)
  • Figure 45. Global Artificial Eye: by Application USD Million (2021-2026)
  • Figure 46. South America Artificial Eye Share (%), by Country
  • Figure 47. Asia Pacific Artificial Eye Share (%), by Country
  • Figure 48. Europe Artificial Eye Share (%), by Country
  • Figure 49. MEA Artificial Eye Share (%), by Country
  • Figure 50. North America Artificial Eye Share (%), by Country
  • Figure 51. Global Artificial Eye: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Erickson Laboratories (Sweden)
  • Integrated Orbital Implants (United States)
  • Ocular Prosthetics (United States)
  • SECOND SIGH (United States)
  • BioSpace (United States)
  • Factor2 (United States)
  • WebMD LLC (United States)
  • Medical Research Foundation (India)
  • Northwest eye design (United States)
  • AEDI (United States)
  • Midwest Eye Laboratories (United States)
  • National Artificial Eye Service (United States)
  • Curzon Group (United Kingdom)
  • Others
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation